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Abstract
Background: We studied the expression of sulphated glycosaminoglycans (GAGs) in coeliac disease (CD) mucosa, as they
are critical determinants of tissue volume, which increases in active disease. We also examined mucosal expression of IL-6,
which stimulates excess GAG synthesis in disorders such as Grave’s ophthalmopathy.
Methods: We stained archival jejunal biopsies from 5 children with CD at diagnosis, on gluten-free diet and challenge for
sulphated GAGs. We then examined duodenal biopsies from 9 children with CD compared to 9 histological normal controls,
staining for sulphated GAGs, heparan sulphate proteoglycans (HSPG), short-chain HSPG (D-HSPG) and the proteoglycan
syndecan-1 (CD138), which is expressed on epithelium and plasma cells. We confirmed findings with a second monoclonal
in another 12 coeliac children. We determined mucosal IL-6 expression by immunohistochemistry and PCR in 9 further cases
and controls, and used quantitative real time PCR for other Th17 pathway cytokines in an additional 10 cases and controls.
Results: In CD, HSPG expression was lost in the epithelial compartment but contrastingly maintained within an expanded
lamina propria. Within the upper lamina propria, clusters of syndecan-1+ plasma cells formed extensive syncytial sheets,
comprising adherent plasma cells, lysed cells with punctate cytoplasmic staining and shed syndecan ectodomains. A dense
infiltrate of IL-6+ mononuclear cells was detected in active coeliac disease, also localised to the upper lamina propria, with
significantly increased mRNA expression of IL-6 and IL-17A but not IL-23 p19.
Conclusions: Matrix expansion, through syndecan-1+ cell recruitment and lamina propria GAG increase, underpins villous
atrophy in coeliac disease. The syndecan-1+ cell syncytia and excess GAG production recapitulate elements of the
invertebrate encapsulation reaction, itself dependent on insect transglutaminase and glutaminated early response proteins.
As in other matrix expansion disorders, IL-6 is upregulated and represents a logical target for immunotherapy in patients
with coeliac disease refractory to gluten-free diet.
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Background
In coeliac disease (CD), distinct architectural changes occur
which reduce the absorptive surface. The characteristic lesion of
active CD consists of villous atrophy, crypt cell hyperplasia and
marked lamina propria leukocyte infiltration [1]. The term villous
atrophy is misleading, since the volume of the lamina propria is
doubled [2]. Two classic studies of the coeliac mucosal lesion
suggest that pathological matrix expansion may occur. Three-
dimensional morphometry by Loehry and Creamer showed that
villous atrophy occurs due to expansion of intervillous lamina
propria, akin to a cake rising during cooking [3]. Shiner identified
electron-microscopic changes in the subepithelial lamina propria
within 24 hours of gluten challenge, characterised by increase in
fibrillar connective tissue together with dense recruitment of
plasma cells, many showing evidence of lysis [4]. Thus villous
atrophy in coeliac disease occurs primarily due to matrix
expansion rather than villous shortening.
The volume of tissues is largely determined by expansion, within
a meshwork of inexpansible fibrils, of a gel matrix composed of
hydrated negatively-charged GAGs, which maintain tissue turgor
through charge-based sequestration of albumin and electrolytes
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[5]. In addition, the strongly anionic heparan sulphate proteogly-
cans (HSPG) play multiple roles in physiology through specific
interaction with numerous cytokines and receptors [6]. Within the
intestine, epithelial HSPG critically limit transepithelial protein
leak, and their loss promotes protein losing enteropathy (PLE), in
synergy with inflammatory cytokines and hydrostatic pressure
[7,8].
Tissue swelling due to cell recruitment and matrix expansion is
a common pathological event which has received relatively little
attention. Disorders characterised by extracellular matrix expan-
sion and excess GAG production include proptosis and acropachy
in autoimmune thyroid disease [9], facial swelling in lepromatous
leprosy [10], many causes of hepatomegaly [11] and chronic
asthma [12]. The mechanisms of tissue expansion include
recruitment of inflammatory cell subsets and a stimulated
hyperproduction of GAGs by fibroblasts and other cells. Such a
combination of inflammatory cell recruitment and stimulated
GAG production is also seen in the invertebrate encapsulation
reaction, first noted by Metchnikoff in starfish larvae, in which
recruited haemocytes palisade around invading pathogens too
large to phagocytose: production of a wall of GAGs by these cells
effectively isolate the invader and deprive it of nutrients [13–15].
The questions thus arise whether stimulated matrix expansion
represents an evolutionarily conserved cell-mediated defense
mechanism and whether there may be commonality of mechanism
in different diseases (including coeliac disease) characterised by
induced matrix expansion.
Increased expression of various potentially matrix-shaping
cytokines, including IFN-c, TNF-a, and IL-6 has been reported
in coeliac disease [1,16]. Amongst candidate cytokines, IL-6 has
particularly strong credentials as a mediator of physiological or
pathological matrix expansion, inducing GAG production
amongst various cell types and in diverse disease states, including
Grave’s disease and gingival hyperplasia [17–19], while hepatic
regeneration does not occur in IL-6 deficient mice unless they
receive exogenous IL-6 [20]. We have thus examined the
hypothesis that villous atrophy in coeliac disease may represent
a disorder of pathological matrix expansion in which IL-6 may be
implicated, and have additionally studied expression of other
components besides IL-6 involved in TH17 pathway responses.
Methods
Patients studied
Formalin-fixed archival jejunal biopsy specimens from the early
1990’s were examined, taken from 5 children undergoing
diagnostic challenge series (biopsies at diagnosis, on a gluten-free
diet and then on gluten challenge). For subsequent studies of
extracellular matrix composition and syndecan-1 expression,
formalin-fixed duodenal biopsies were obtained from 9 children
with active coeliac disease and anti-endomysium and/or anti-
tissue transglutaminase antibody positivity. Duodenal biopsies
were also obtained from 9 children who had GI symptoms
sufficient to warrant endoscopy but were found to have
histologically normal tissues and negative coeliac serology (normal
controls). Staining patterns for syndecan-1 and sulphated GAGs
were then confirmed with a different antibody in a further 12
coeliac biopsies and one control. All children underwent routine
diagnostic endoscopy at either the Meyer Hospital, Florence, Italy,
the Royal Free Hospital, London, UK or University Hospital
Coventry and Warwickshire, Coventry, UK. Patients ranged from
2 to 16 years, with no differences between groups in age
distribution.
For studies of IL-6 PCR and immunohistochemistry, snap-
frozen biopsies from an additional 9 children with active coeliac
disease and 9 histologically normal controls were analysed. For
study of Th17 pathway mRNA, frozen biopsies from a further 10
children with coeliac disease and 8 histologically normal controls
were obtained. Approval for additional biopsies was obtained from
the Research Ethics Committees of the Meyer Hospital and the
Royal Free NHS Trust and written informed consent was
obtained from parents in all cases. Biopsies from children at
University Hospital Coventry were obtained from the University
of Birmingham Biomaterials Resource Centre, following approval
by their Access Review Panel. Written informed consent for
research use had been obtained in all cases from parents prior to
the tissues being deposited in the Biomaterials Resource Centre.
Histological assessment of the biopsies from the CD patients
showed subtotal or total villous atrophy with increased intraepi-
thelial lymphocytes (IELs), whereas controls showed normal
duodenal histology without increase in IELs. No gastrointestinal
abnormality was eventually diagnosed in the control patients.
Tissue analysis
6 mm sections were cut by cryostat onto poly-L-lysine coated
slides and fixed in 4% paraformaldehyde or acetone for IL-6
staining, while GAGs were localised on formalin-fixed specimens.
The distribution of sulphated GAGs was studied with a 5 nm gold-
conjugated poly-L-lysine probe (1:100 in phosphate-buffered
saline, pH 1.2, British Biocell International, Cardiff, UK) with
silver enhancer as previously reported [8,21]. Serial sections were
stained using immunohistochemistry. Endogenous peroxidase
activity was blocked with 3% H2O2 in methanol. Primary mouse
monoclonal antibodies used included anti-human HSPG (Seiga-
kaku, UK, dilution 1:50), D-HSPG, recognising short chain HSPG
‘‘stubs’’ after one hour heparitinase digestion (Seikagaku UK,
1:50), syndecan-1 (Clones MCA681H 1:100, MCA2459GA 1:200,
Serotec UK). IL-6 was localised using a goat anti-human IL-6
antibody (R&D Systems, UK, 1:100) followed by rabbit anti-goat
immunoglobulins (1:80, Dako, UK), with staining optimised on
sections of tonsil. Bound antigens were localised following
manufacturers’ instructions using avidin-biotin immunohisto-
chemistry (Vectastain Elite, Vecta). Syndecan-1 clone
MCA2459GA was visualised using Novocastra Novolink polymer
detection system (Leica Biosystems, UK).
Quantitation of staining intensity for sulphated GAGs, HSPG,
D-HSPG and syndecan-1 was performed by computerised analysis
using ImageJ software (http://rsb.info.nih.gov/ij/) in both epi-
thelial and lamina propria compartments as previously reported
[21]. Colour deconvolution was used to separate specific di-amino-
benzidine (DAB) or silver staining from counterstain prior to
region-of-interest densitometry. Separate quantitation was done in
the lamina propria and intraepithelial compartments. For the
lamina propria, a single field was drawn around the entire
compartment excluding crypts. For the epithelium, high-power
images were used, and a mean density was derived for each
specimen from quantitation of multiple individual intercellular
spaces. Quantitation was on an inverse scale (1–250), based on
light transmission, and staining intensity values are presented in
reciprocal form (1/transmission intensity 6104 minus 40 (back-
ground constant), as previously reported [21]. All statistical
analysis was performed on initial transmission intensity data.
Quantitation of lamina propria area per unit epithelial length was
performed on the same slides using ImageJ quantitation, excluding
all epithelial crypts.
Quantitation of positively stained IL-6+ cells within the lamina
propria was performed per high-powered field (400-fold magni-
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fication, equivalent to 0.2 mm2), evaluating at least four areas per
slide. All sections were blindly and independently examined by
two observers, for whom interobserver results varied by less than
8%.
RNA Isolation for IL-6 PCR
Biopsies were disrupted using DEPC treated glass tissue grinders
and homogenised using QIAshredder spin columns (Qiagen, UK).
Total RNA was isolated from biopsies with a monophasic solution
of phenol and guanidin isothiocyanate (TRIzol, Invitrogen, CA,
USA) and chloroform. Precipitation was obtained with isopropa-
nolol, using RNeasy Micro columns (Qiagen, UK) according to
the manufacturer’s instructions. RNA concentration was deter-
mined by absorption at 260 nm, and the 260/280 nm absorption
ratios of the samples were .2. The integrity of the total RNA was
assessed using a 1.5% ethidium bromide-stained agarose gel. Only
samples with clearly defined 18S and 28S ribosomal RNA peaks
were used in the study. To remove genomic DNA contamination,
RNA samples were subjected to DNase treatment using a
TURBO DNase-free kit (Ambion, UK), following the manufac-
turer’s protocol for extended digestion.
RNA integrity was assessed by subjecting cDNA to amplifica-
tion by PCR of G3PDH house-keeping gene. Complementary
DNA (cDNA) was obtained from 1.5 mg of total RNA using
Superscript First-Strand Synthesis System for RT-PCR (Invitro-
gen, CA, USA) and amplified with Platinum Taq DNA
Polymerase (Invitrogen, CA, USA), following the manufacturer’s
instructions. Primers for human IL-6 were provided by R&D
Systems, UK. 100 ng of random hexamers, 275 ng of oligo (dT)18
and 50 U of BioScript Reverse Transcriptase were used in each
reaction. Duplicate reactions omitting the BioScript Reverse
Transcriptase were also carried out. Amplification was performed
for 36 cycles, each cycle consisting of denaturation at 94uC,
annealing at temperatures appropriate for each primer pairs (55–
70uC) and extension at 72uC. CDNA was diluted 1:4 in TE buffer
(10 mM Tris-HCL, 0.1 mM EDTA, pH = 8.0), and stored as
aliquots at 220uC. An electrophoresis in ethidium bromide
stained 1.2% agarose gel (Agarose I, Amresco, USA) was run and
PCR products were visualized by UV. Negative controls (mix
without cDNA samples) were run with each PCR assay. The
quantitation of PCR products was determined using the Gel Doc
2000 gel documentation system (Bio-Rad, UK). Band density was
normalised to the housekeeping gene GAPDH.
Real-time quantitative PCR (Q-PCR) for IL-17 pathway
cytokines
Primers (table 1) were designed using Primer3 software (http://
frodo.wi.mit.edu/), using stringent maximum self complementary
and 39 self complementary alignment scores to minimise the
formation of primer-dimers. Primer sequences for TBP and
HRPT1 were down loaded from the public RTPrimerDB2
database (http://medgen.UGent.be/rtprimerdb/), RTPrimerDB
ID: TBP(2627), HPRT1(984). Primers were synthesised by VH-
BIO, UK.
Q-PCR was performed in a Mastercycler ep realplex thermal
cycler (Eppendorf, UK), using a QuantiTect SYBR Green PCR
kit (Qiagen, UK). Amplification reactions were carried out in a
volume 20 ml comprising 10 ml of QuantiTect master mix, 0.5 mM
of forward and reverse primers in a total volume of 1 ml (with the
exception of primers for PSMB6 which were used at a
concentration of 0.3 mM), 1 ml cDNA and 7.5 ml water. The
PCR parameters comprised an initial hot start step of 15 minutes
at 95uC, followed by 45 cycles of 95uC for 30 seconds, 58uC for 30
seconds and 72uC for 30 seconds. PCR product specificity was
analysed by melting curve analysis and by running PCR products
on 2% ethidium bromide agarose gels. Ct values for each gene
were acquired using the noise band detection freshold option on
the Mastercycler software. Each sample was analyzed in triplicate,
and the mean of the Ct values was calculated. In addition, RT-
samples and no template controls were included in each run to
excluded false signals generated by contaminating genomic DNA
or primer-dimer formation. To ensure similar PCR amplification
efficiencies for each gene, standard curves were constructed using
5 four fold serial dilutions of cDNA. Each gene demonstrated
comparable amplification efficiencies of between 90% and 96%.
To determine the most stable reference genes to use in the
study, the expression stability of a range of housekeeping genes was
analysed using the geNorm VBA applet for Microsoft Excel
(http://medgen.ugent.be/,jvdesomp/genorm/). Housekeeping
genes were ranked by pairwise expression stability (M) and the
optimum number of reference genes to use for normalisation was
determined by using a cut off value of 0.15 for pair wise variation
(V). The difference in relative expression between the coeliac and
control groups was determined using the DCt method. The
geometric means of the most stable set of housekeeping genes were
used to normalise expression values.
Statistical analysis
Statistical analysis for staining intensity was performed using
Statgraphics software, comparing group means derived from single
mean values for each case. Staining intensity was compared
between coeliac disease and normal controls for epithelial and
lamina propria compartments using the unmatched t test, with
level of significance at p,0.05. Data are presented as mean 6
95% confidence intervals (95CI). The number of IL-6+ cells per
high-powered field was expressed as mean 6 standard deviation
and the data were compared using the unmatched t test.
Statistical analyses for real-time PCR were performed using
SPSS 13 for Windows. Differences between genotypes were
evaluated using a two-tailed Mann-Whitney U-test. A P value of
,0.05 was considered as statistically significant.
Results
Study of archival specimens from the 5 children undergoing
repeated biopsy at diagnosis, on gluten-free diet and on gluten
challenge demonstrated similar features in all cases. Epithelial and
subepithelial basement membrane sulphated GAG expression was
strongly reduced at diagnosis, while expression within the lamina
propria appeared increased (Figure 1). All showed contrasting
findings on gluten-free diet, similar to those previously reported in
normal duodenum [21], with restored GAG expression on the
basolateral epithelial surface and in the subepithelial basement
membrane, together with restoration of normal architecture.
Gluten challenge induced loss of epithelial GAGs and apparent
increase in lamina propria expression. One striking feature of the
active coeliac lesion was the stronger expression of membrane-
bound sulphated GAGs on clustered lamina propria mononuclear
cells compared to during gluten-free diet (Figure 1).
Quantitation of mucosal GAG expression
Comparative quantitation of differential GAG/HSPG expres-
sion, performed in duodenal biopsies from 9 cases and 9
histologically normal controls, confirmed and extended these
findings to demonstrate clear differences between epithelial and
lamina propria compartments (Figures 2, 3, Figures S1, S2, S3).
Within the epithelium there was significant reduction in GAG
chain expression in active coeliac disease, with sulphated GAG,
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HSPG and short-chain D-HSPG staining intensity all decreased
compared to controls. By contrast, expression of the core protein
molecule syndecan-1 was maintained similar to normal controls
and with normal basolateral epithelial localisation. These findings
indicate either impairment of epithelial GAG glycan chain
extension and sulphation, or their extensive degradation after
synthesis.
Table 1. Primer sequences for real time quantitative PCR studies of IL-17 pathway components and for optimisation of
housekeeping genes.
Housekeeping Genes
Entrez
gene I.D Forward Sequence Reverse Sequence
TBP 6908 TGCACAGGAGCCAAGAGTGAA CACATCACAGCTCCCCACCA
POLR2A 5430 GATGGGCAAAAGAGTGGACTT GGGTACTGACTGTTCCCCCT
HPRT1 3251 GCCAGACTTTGTTGGATTTG CTCTCATCTTAGGCTTTGTATTTTG
GAPDH 2597 AGGTCGGAGTCAACGGATTT TGGAAGATGGTGATGGGATTT
B2M 567 GGGTTTCATCCATCCGACA ACACGGCAGGCATACTCATC
ACTB 60 AAACTGGAACGGTGAAGGTG CCTGTGTGGACTTGGGAGAG
RPLPO 6175 GCAATGTTGCCAGTGTCTG GCCTTGACCTTTTCAGCAA
PSMB6 5694 AGACTGGGAAAGCCGAGAAG ATGCGGTCGTGAATAGGTGT
Genes of Interest
IL17a 3605 AGGAATCACAATCCCACGAA ACTTTGCCTCCCAGATCACA
IL6 3569 AACCTGAACCTTCCAAAGATGG TCTGGCTTGTTCCTCACTACT
IL23a 51561 GGACAACAGTCAGTTCTGCTT CACAGGGCTATCAGGGAGC
TGFb1 7040 GCGTGCTAATGGTGGAAAC CGGTGACATCAAAAGATAACCAC
doi:10.1371/journal.pone.0106005.t001
Figure 1. Expression of sulphated GAGs within archival small intestinal biopsies from two patients with coeliac disease during a
biopsy challenge series following previous ESPGHAN guidelines. The biopsies shown were taken from the children at initial diagnosis (top
row), then on a gluten-free diet (centre row) and finally following gluten challenge (bottom row). The left hand column shows low power views
(original magnification 610) of case 1, and the right hand column high power (x40) views of epithelial staining in case 2. The specimens show
decreased epithelial and increased lamina propria sulphated GAG expression in active coeliac disease compared to findings in the same patient on a
gluten-free diet. Strong pericellular staining may be seen on aggregated lamina propria mononuclear cells. Similar findings were seen in 3 other
cases.
doi:10.1371/journal.pone.0106005.g001
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Contrasting findings within the lamina propria demonstrated
evidence of matrix expansion and increased total GAGs. Lamina
propria area was substantially increased, consistent with previous
reports [2,3], at 4.1 mm2/mm epithelial length (95% CI 3.6–4.6)
in comparison to 2.5 mm2/mm (2.1–2.9) in controls (p,0.0001).
Within this compartment, staining intensities for sulphated GAGs,
HSPG and D-HSPG stubs were maintained overall similar to
controls (Figures 2, 3, Figures S1, S2, S3). Thus the overall GAG
content of the lamina propria was increased, demonstrating that
matrix expansion, at least in part, relates to increased sulphated
GAG production.
Mucosal expression of syndecan-1 (CD138)
Identical staining patterns were noted for both MCA681H and
MCA2459GA syndecan-1 monoclonals. Syndecan-1 was strongly
expressed on the enterocyte basolateral surface in normal small
intestine using both antibodies, as previously reported [21]. In
contrast to its GAG side chains, syndecan-1 core protein
expression was maintained on enterocyte basolateral membrane
in coeliac disease, with staining intensity similar to normal small
bowel (Figures 2, 4, Figure S4). Localisation of sulphated GAGs
on the 12 specimens and one control examined using
MCA2459GA showed similar features of epithelial loss and
lamina propria preservation as seen in the quantitated specimens
(Figure S5).
Figure 2. Staining density for glycosaminoglycans within (a) epithelium and (b) lamina propria, in coeliac disease mucosa in
comparison to controls. Sulphated GAGs, heparan sulphate proteoglycans (HSPG) and short chain heparan sulphate proteoglycan ‘‘stubs’’ (D-
HSPG) are shown for both epithelial and lamina propria compartments, while the core protein for epithelial proteoglycans (syndecan-1) is shown for
the epithelial compartment alone. Epithelial expression of heparan sulphate and sulphated GAGs is reduced in coeliac disease compared to controls,
whereas the core protein syndecan-1 is maintained. Within the lamina propria the density of expression of heparan sulphate and sulphated GAGs is
maintained similar to controls. Values shown represent means plus 95% confidence intervals. While the units displayed are derived from reciprocals
of initial measurement minus background, statistical comparisons were made on unmodified initial measurements, as previously reported 21.
Symbols: Significant difference between coeliac and controls: * p,0.05, ** p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0106005.g002
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Within the lamina propria, individual syndecan-1+ plasma cells
could be noted within the lamina propria in all histologically
normal controls (Figures 4 A,B). Some localised clustering was
seen in 2/10 cases. In all 21 coeliac cases, a striking aggregation of
syndecan-1+ cells could be seen within the upper lamina propria,
forming extensive syncytial sheets which represented the major
volume component of the upper lamina propria (Figure 4). At
higher magnification, the syncytia comprised both plasma cells
with strong epithelial staining, and additional cells with identifiable
nuclei and punctate intracellular staining but without strong
membrane staining. (Figure 4 E,F,J). In addition, extracellular
deposition of syndecan-1 could be seen in all aggregates,
representing shed syndecan ectodomains. In cases where serial
biopsies showed better preservation of normal villous architecture,
there was corresponding reduced syncytial syndecan-1 cell
aggregation (Figure 4 G,H compared to I,J).
Mucosal expression of IL-6 and Th17 pathway cytokines
Expression of IL-6 was strongly enhanced within the mucosa of
a further 9 children with coeliac disease compared to normal
duodenum. Immunohistochemical analysis demonstrated that IL-
6 expression was largely confined to cells within the lamina propria
(Figure 5a). The IL-6+ cells included small dark staining
lymphocyte-like cells and larger irregular cells of characteristic
macrophage morphology. The epithelium did not express IL-6
immunoreactivity. The mean density of IL-6+ cells within the
lamina propria (Figure 5b) was significantly higher in coeliac
disease (104.7613.1/high power field) compared to normal
controls (22.2616.1, p,0.05). RT-PCR evaluation in matched
biopsies also demonstrated marked increase of IL-6 mRNA in
coeliac disease compared to controls (Figure 5c, Figure S6), with
mean expression density 508 vs 68/mm2, normalised to GAPDH
0.68 vs 0.05 (p,0.014).
Quantitative real-time PCR for IL-6, and for other components
of the TH17 pathway (IL-17, IL-23 p19 and TGF-b1) showed a
30.9-fold median increase for IL-17A (p,0.02), a 4.0 -fold
increase for IL-6 (p,0.05), but without significant increase for IL-
23 p19 and TGF-b1 mRNA (Figure 6, Figure S7).
Conclusions
Matrix changes in coeliac disease are distinct from in IBD,
which shows widespread loss of mucosal sulphated GAGs [22]. In
coeliac disease, GAG disruption is limited to the epithelial
compartment, while the lamina propria shows undiminished
sulphated GAG expression. By contrast, unsulphated hyaluronan
has been shown to be patchily decreased in coeliac mucosa [23].
Limitations imposed by biopsy size currently preclude more formal
glycobiochemical assessment. While we measured tissue area as a
proxy for volume, this cannot be directly determined from biopsy
sections, though previous mathematical modelling suggests an
approximate doubling of volume in coeliac disease [2].
Loss of epithelial HSPG promotes protein leak into the lumen
[7,8]. Our findings of lost epithelial HSPG will contribute to the
increased albumin leak in coeliac disease [24]. The rarity of
coeliac crisis, characterised by severe PLE, is likely due to
retardation of albumin within the coeliac lamina propria in an
expanded anionic gel [24], comprising aggregates of negatively
charged syndecan-expressing leukocytes in a matrix of sulphated
GAGs. Acute infection, the usual trigger of coeliac crisis, will
induce vascular albumin leak and upregulation of mucosal matrix
degrading metalloproteases, thus delivering unrestricted albumin
Figure 3. Representative staining for sulphated GAGs, HSPG and D-HSPG stubs in control (top row) and coeliac cases (middle and
bottom row). All views are at same magnification (original 640). In the control biopsies, there is strong expression of heparan sulphate and
sulphated GAGs within the subepithelial basement membrane and on the basolateral surface of epithelial cells, most marked towards the villous tip.
The coeliac biopsies show loss of HSPG and sulphated GAG expression within the basement membrane and from the basolateral epithelial surface. By
contrast there is maintained expression within the lamina propria. Additional images from each of the patients studied can be seen in Figures S1 and
S2. Quantitative staining intensity data derived from colour deconvoluted images (Figure S3) are shown in Figure 2.
doi:10.1371/journal.pone.0106005.g003
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to the HSPG-depleted basement membrane and epithelium to
promote PLE.
We found that much of the mucosal GAGs in coeliac disease
localises within syncytial aggregates of syndecan-1+ plasma cells,
cell remnants with intracytoplasmic staining and shed syndecan
ectodomains. Classic studies of gluten-induced changes in coeliac
disease showed that villous atrophy is caused by swelling of the
intervillous ridges [3] and that gluten-induced matrix deposition in
the lamina propria was characterised by dense aggregation of
plasma cells - many lysed with loss of their limiting membrane [4].
These features are entirely consistent with our findings.
We hypothesise that our findings, of syndecan-1+ cell syncytial
aggregation with excess GAG production, recapitulate core
elements of the invertebrate encapsulation reaction, in which
insect haemocytes form palisades around an invading pathogen or
object too large to phagocytose [13–15,25,26]. Many initially
binding cells undergo lysis, while subsequent adhering cells form
extensive sheets to wall off the pathogen. GAG production is
stimulated [13–15,26], providing a physiological barrier to
nutrient absorption. Recruited cells are characterised by syndecan
expression [27], required for invertebrate haemocyte binding to
laminin and cell cluster formation [28]. Our findings in coeliac
mucosa show a similar palisading of syndecan-expressing leuko-
cytes to form syncytial aggregates, together with a lysis of a
proportion of these cells, with loss of their plasma membrane.
Sulphated GAG including HSPG accumulated around these
aggregates in an expansion of the lamina propria. In insects, the
GAG production and matrix expansion is limited by a subsequent
melanisation reaction dependent on the enzyme prophenoloxidase
[29], in which haemocyte responses are downregulated by a-
melanocyte stimulating hormone (a-MSH) [30]. In coeliac mucosa
the gliadin-induced IL-6 response is similarly attenuated by a-
MSH [31].
A contrasting interpretation of our findings is that the plasma
cell aggregates may represent a peripheral niche for plasma cell
survival [32]. Membrane syndecan-1 is critical for long-term
survival of plasma cells, binding to mediators such as APRIL and
CXCL12 that prevent apoptosis [33]. IL-6 also plays an important
role in maintaining plasma cell survival in the periphery [32].
While such a niche cannot be excluded, it is notable that many of
the plasma cells show evidence of lysis [3], a characteristic of
invertebrate encapsulation [13–15].
The encapsulation reaction has additional specific similarities to
coeliac disease, as encapsulation is dependent on both insect
transglutaminase expression [34] and two gliadin-like early
encapsulation proteins [35]. Could exogenous gliadin thus trigger
this response? It is notable in this context that the glutenin moiety
of wheats provides an effective barrier to predation by most insect
species, and there are notably few successful phytophagous
predators. Insects able to predate wheat share a common ability
to predigest gluten with salivary enzymes, which has evolved
separately in species from the northern and southern hemispheres.
The Sunn bug Eurygaster integricepts, a major pest in southern
Europe, north Africa and Asia, secretes glutenin-specific serine
proteases in its saliva, cleaving gliadin at glutamine residues
between consensus hexapeptide and nonapeptide repeats [36,37].
The New Zealand wheat bug, Nysius huttoni, secretes a more
specific salivary proteinase species, cleaving between glutamine
and glycine residues within hexapetide repeats [38]. Insect-
predated wheat shows abnormalities in the ability to make dough,
because of this molecular disruption [36–38]. The role of glutenins
in dough production was critical in Neolithic times, leading to
early selection for high glutenin wheats [39]. It would be ironic if
the dietary constituent that played such a role in advancing human
socio-economic development had evolved in plant host defense as
a trigger of innate immunity in predators.
Our finding of shed syndecan ectodomains may provide a link
between innate immune response to gliadins and the MHC-
restricted adaptive immune response characteristic of coeliac
disease. One unexplained mechanism in coeliac disease is the
triggering of extracellular release of TG2 and its subsequent
activation, necessary for deamidation of gluten and adaptive
immune responses [40]. Syndecan shedding is critical in the
release of TG2 from cells into the extracellular milieu, through
specific binding of TG2 to syndecan HS chains [41]. In
Figure 4. Syndecan-1 (CD138) expression in normal and coeliac
mucosa using monoclonal MCA2459GA. A. Expression within
normal intestine, showing syndecan-1 localises predominantly to the
basolateral epithelial surface (original magnification 610). B. Higher
power view (x40) of normal duodenum, showing similar epithelial
localisation plus the presence of scattered syndecan-1+ plasma cells
within the lamina propria. C,D. Low power view (x10) of 2 cases of
coeliac disease, showing retention of epithelial staining similar to
controls, plus additionally a dense confluent expression within the
upper lamina propria. E,F. Higher power view (x40) of the subepithelial
region in these cases. The lamina propria aggregates consist of cells
with dense membrane staining (plasma cells), cells with recognisable
nuclei and punctate cytoplasmic staining and scattered syndecan-1+
debris (shed ectodomains). G–J. Findings within the same case in two
biopsies showing contrasting areas with containing areas with
preserved villous architecture (G,H) and villous atrophy (I,J). G,I are at
low power (x10), H,J at high power (x 40). The biopsy with villous
atrophy shows dense subepithelial syndecan-1 syncytial expansion in
comparison to that with preserved villous architecture. Mucosal
syndecan-1 expression from all normal controls and coeliac patients
studied is shown in Figure S4.
doi:10.1371/journal.pone.0106005.g004
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enterocytes the uptake of a(2)-gliadin-mer is facilitated by the small
GTP-ase Rab5 [42], which interacts with the cytoplasmic tail of
syndecan-1 to regulate ectodomain shedding [43]. Following TG2
release, the presence of calcium and inhibition of local oxidation
are critical for its activation [40]. Known functions of HS include
local sequestration of cations and binding of superoxide dismutase
[6], thus potentially allowing shed syndecan ectodomains to
provide a milieu favourable to TG2 activation.
Excess mucosal IL-6 production has been shown to occur in
coeliac disease and to differentiate it from non-coeliac gluten
Figure 5. a). IL-6 localisation by immunohistochemistry in 2 controls (top panel) and 4 cases of coeliac disease (lower 2 panels). The left column show
low power (original magnification 610) and the right column high power (x40) views. The coeliac patients showed increased numbers of IL-6+
mononuclear cells within the lamina propria but not epithelial compartments. b). Quantitative data for mucosal IL-6+ cell density in 9 coeliac and 9
control biopsies, expressed as IL-6+ cells per high power field. c). Mucosal IL-6 mRNA expression density normalised to the housekeeping gene
GAPDH in matched biopsies from the same cases.
doi:10.1371/journal.pone.0106005.g005
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intolerance, in which enhanced innate immune responses also
occur but without adaptive changes [16]. We did not formally
characterise the IL-6 producing cells, but noted lymphocyte-like
and macrophage-like populations, without evidence of epithelial
immunoreactivity. IL-6 has multiple functions in immune
regulation and inflammation, and is particularly important in
autoimmune diseases. It regulates the balance between generation
of IL-17 producing cells and T regulatory cells towards an
inflammatory response, by promoting development of Th17 cells
in concert with TGF-b while blocking TGF-b induced production
of Treg cells [44]. Other Th17 pathway components are increased
within coeliac mucosa [45,46], with exposure to IL-15 promoting
a Th17 response to gliadin by monocytes [47]. Whether other
Th17 cytokines may contribute to pathological matrix expansion,
as does IL-6 [17–20], is currently unclear.
Gliadin peptides have been shown induce a significant innate
immune response in epithelium, mucosal macrophages and
dendritic cells in humans, both with and without coeliac disease,
as well as in murine cells [45,48–55]. We propose that elements of
this innate response contribute to the characteristic architectural
disturbance in coeliac disease in a fashion analogous to the insect
encapsulation reaction, through cell recruitment and induced
matrix expansion. In refractory coeliac disease, where villous
atrophy persists despite gluten free diet, mucosal IL-6 expression is
further increased [56] and its systemic release enhanced, especially
in enteropathy associated T cell lymphoma [57]. IL-6 may
represent a pivotal target for immunotherapy in refractory coeliac
disease.
Supporting Information
Figure S1 Serial sections from the 9 control duodenal biopsies
studied for matrix quantitation, stained for heparan sulphate
proteoglycan (HSPG), short-chain heparan sulphate (D-HSPG) by
immunohistochemistry and sulphated GAGs by specific charge-
based immunohistochemistry (original magnification620).
(TIF)
Figure S2 Serial sections from the 9 coeliac duodenal biopsies
studied for matrix quantitation, stained for heparan sulphate
proteoglycan (HSPG), short-chain heparan sulphate (D-HSPG) by
immunohistochemistry and sulphated GAG by specific charge-
based immunohistochemistry (original magnification620).
(TIF)
Figure S3 Colour-deconjugated images, separated by ImageJ, of
the 9 control and 9 coeliac specimens used for densitometric
assessment. Deconvoluted DAB staining is shown for HSPG
(upper panel) and D-HSPG (middle panel), while deconvoluted
silver staining is shown for sulphated GAGs (lower panel). The
images show preservation of basement membrane and basolateral
epithelial expression in controls compared to loss in coeliac
disease.
(TIF)
Figure S4 Staining for syndecan-1 (CD138) with two monoclo-
nals. The upper 3 rows show syndecan-1 staining for staining in
normal controls using clone MCA681H. The same monoclonal is
shown for the matched coeliac disease biopsies in rows 3–6 (all at
original magnification 620). These specimens were used for the
matrix quantitation studies shown in Figure 2. The slides
demonstrate preserved epithelial basolateral staining in the coeliac
biopsies together with the presence of confluent subepithelial
Figure 6. Quantitative analysis of mRNA expression for IL-17a, IL-6, IL-23a and TGF-b1 in biopsies from 10 children with coeliac
disease and 8 histologically normal controls. For each cytokine, the left column represents results for coeliac disease and the right column
results from controls. Il-17A and IL-6 showed significant increase in coeliac disease. Original data shown in Figure S7.
doi:10.1371/journal.pone.0106005.g006
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aggregates of CD138+ plasma cells. Rows 7–10 demonstrate
staining for syndecan-1 using clone MCA2459GA in 12 additional
duodenal biopsies from children with coeliac disease obtained
from the University of Birmingham Biomaterials Resource Centre
(original magnification620). The staining was visualised with the
Novocastra Novolink polymer detection system, giving a darker
reaction product. The single panel in row 11 is an additional
control specimen stained with clone MCA2459GA.
(TIF)
Figure S5 Staining for sulphated GAGs in the 12 coeliac
biopsies obtained from the University of Birmingham Biomaterials
Resource Centre, showing similar features of maintained lamina
propria but lost epithelial staining to those seen in the quantitation
study specimens (Figure S2).
(TIF)
Figure S6 RT-PCR analysis of IL-6 mRNA in normal controls
(upper panel) and coeliac disease (lower panel). Quantitative data
is shown in Figure 5c.
(TIF)
Figure S7 A. Determination of the most stable housekeeping
gene for IL-17 pathway PCR studies. The tata binding protein,
proteosomal membrane bound protein 6 and b2-microglobulin
genes performed most stably and were used as references. B. Use
of the stable housekeeping gene panel to determine relative
expression of IL-17 pathway genes. C. Determination of fold-
difference expression for IL-17 pathway genes. These data were
used to formulate Figure 6.
(TIF)
Acknowledgments
We thank Dr Anthony Shmygol for his guidance with Image J analysis.
Author Contributions
Conceived and designed the experiments: CS ML FT ADP SHM.
Performed the experiments: CS ML PL FT SJ ADP SHM. Analyzed the
data: CS ML FT ADP SHM. Contributed reagents/materials/analysis
tools: ML PL SJ ADP. Contributed to the writing of the manuscript: CS
SHM.
References
1. Abadie V, Sollid LM, Barreiro LB, Jabri B (2011) Integration of genetic and
immunological insights into a model of celiac disease pathogenesis. Annu Rev
Immunol 29: 493–525.
2. Dhesi I, Marsh MN, Kelly C, Crowe P (1984) Morphometric analysis of small
intestinal mucosa II. Determination of lamina propria volumes, plasma cell and
neutrophil populations within control and coeliac disease mucosa. Virchow’s
Arch 403: 173–80.
3. Loehry CA, Creamer B (1969) Three-dimensional structure of the human small
intestinal mucosa in health and disease. Gut 10: 6–12.
4. Shiner M (1973) Ultrastructural changes suggestive of immune reactions in the
jejunal mucosa of coeliac children following gluten challenge. Gut 14: 1–12.
5. Comper WD, Laurent TC (1978) Physiological function of connective tissue
polysaccharides. Physiol Rev 58: 255–315.
6. Bishop JR, Schuksz M, Esko JD (2007) Heparan sulfate proteoglycans fine-tune
mammalian physiology. Nature 446: 1030–1037.
7. Bode L, Murch S, Freeze HH (2006) Heparan sulfate plays a central role in a
dynamic in vitro model of protein-losing enteropathy. J Biol Chem 281: 7809–
7815.
8. Bode L, Salvestrini C, Park PW, Li JP, Esko JD, et al (2008) Heparan sulfate and
syndecan-1 are essential in maintaining intestinal epithelial barrier function.
J Clin Invest 118: 229–238.
9. Bahn RS, Heufelder AE (1993) Pathogenesis of Graves’ ophthalmopathy.
N Engl J Med 329: 1468–1475.
10. Antunes SL, Gallo ME, de Almeida SM, Mota EE, Pelajo M, et al (1999)
Dermal extracellular matrix in cutaneous leprosy lesions. Int J Lepr Other
Mycobact Dis 67: 24–35.
11. Gressner AM (1994) Activation of proteoglycan synthesis in injured liver—a
brief review of molecular and cellular aspects. Eur J Clin Chem Clin Biochem
32: 225–237.
12. Huang J, Olivenstein R, Taha R, Hamid Q, Ludwig M (1999) Enhanced
proteoglycan deposition in the airway wall of atopic asthmatics. Am J Respir
Crit Care Med 160: 725–729.
13. Salt G (1963) The defence reactions of insects to metazoan parasites.
Parasitology 53: 527–642.
14. Williams MJ (2007) Drosophila hemopoiesis and cellular immunity. J Immunol
178: 4711–4716.
15. Vinson SB (1990) How parasitoids deal with the immune system of their host: an
overview. Arch Insect Biochem Physiol 13: 3–27.
16. Sapone A, Lammers KM, Casolaro V, Cammarota M, Giuliano MT, et al
(2011) Divergence of gut permeability and mucosal immune gene expression in
two gluten-associated conditions: celiac disease and gluten sensitivity. BMC Med
9: 23.
17. Duncan MR, Berman B (1991) Stimulation of collagen and glycosaminoglycan
production in cultured human adult dermal fibroblasts by recombinant human
interleukin 6. J Invest Dermatol 97: 686–692.
18. Chen B, Tsui S, Smith TJ (2005) IL-1b induces IL-6 expression in human orbital
fibroblasts: identification of an anatomic-site specific phenotypic attribute
relevant to thyroid-associated ophthalmopathy. J Immunol 175: 1310–1319.
19. Morton RS, Dongari-Bagtzoglou AI (1999) Regulation of gingival fibroblast
interleukin-6 secretion by cyclosporine A. J Periodontol 70: 1464–1471.
20. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto C, Furth EE, et al
(1996) Liver failure and defective hepatocyte regeneration in interleukin-6-
deficient mice. Science 274: 1379–1383.
21. Amadi B, Fagbemi AO, Kelly P, Mwiya M, Torrente F, et al (2009) Reduced
production of sulfated glycosaminoglyans occurs in Zambian children with
kwashiorkor but not marasmus. Am J Clin Nutr 89: 592–600.
22. Murch SH, MacDonald TT, Walker-Smith JA, Levin M, Lionetti P, et al (1993)
Disruption of sulphated glycosaminoglycans in intestinal inflammation. Lancet
341: 711–4.
23. Kemppainen T, Tammi R, Tammi M, Agren U, Julkunen R, et al (2005)
Elevated duodenal expression of hyaluronan and its CD44 receptor in the
duodenal mucosa of coeliac patients. Histopathology 2005, 46: 64–72.
24. Lavo¨ B, Knutson L, Lo¨o¨f L, Odlind B, Ha¨llgren R (1990) Signs of increased
leakage over the jejunal mucosa during gliadin challenge of patients with coeliac
disease. Gut 31: 153–157.
25. Parrinello N, Patricolo E (1984) Inflammatory-like reaction in the tunic of Ciona
intestinalis (Tunicata). II. Capsule components. Biol Bull 167: 238–250.
26. Crompton DW (1964) The envelope surrounding Polymorphus minutus (Goeze,
1782) (Acanthocephala) during its development in the intermediate host,
Gammarus pulex. Parasitology 54: 721–735.
27. Spring J, Paine-Saunders S, Hynes RO, Bernfield M (1994) Drosophila
syndecan: conservation of a cell-surface heparan sulphate proteoglycan. Proc
Natl Acad Sci USA 91: 3334–3338.
28. Narita R, Yamashita H, Goto A, Imai H, Ichihara S, et al (2004) Syndecan-
dependent binding of Drosophila hemocytes to laminin a3/5 chain LG4-5
modules: potential role in sessile hemocyte islets formation. FEBS Letters 576:
127–132.
29. Chen CC, Laurence BR (1987) In vitro study on humoral encapsulation of
microfilariae: effects of diethyldithiocarbamate and dopachrome on the reaction.
Int J Parasitol 17: 789–794.
30. Grimaldi A, Tettamanti G, Congiu T, Girardello R, Malagoli D, et al (2012)
The main actors involved in parasitization of Heliothis virescens larva. Cell
Tissue Res 350: 491–502.
31. Colombo G, Buffa R, Bardella MT, Garofalo L, Carlin A, et al (2002-3) Anti-
inflammatory effects of a-melanocyte-stimulating hormone in celiac intestinal
mucosa. Neuroimmunomodulation 10: 208–216.
32. Radbruch A, Muehlinghaus G, Luger EO, Inamine A, Smith KG, et al (2006)
Competence and competition: the challenge of becoming a long-lived plasma
cell. Nat Rev Immunol 6: 741–750.
33. Reijmers RM, Spaargaren M, Pals ST (2013) Heparan sulfate proteoglycans in
the control of B cell development and the pathogenesis of multiple myeloma.
FEBS J 280: 2180–2193.
34. Wang Z, Wilhelmsson C, Hyrsl P, Loof TG, Dobes P, et al (2010) Pathogen
entrapment by transglutaminase – a conserved early innate immune mechanism.
PLOS Pathogens 6 (2): e1000763.
35. Cho MY, Lee HS, Lee KM, Homma K, Natori S, et al (1999) Molecular cloning
and functional properties of two early-stage encapsulation-relating proteins from
the coleopteran insect, Tenebrio molitor larvae. Eur J Biochem 262: 737–744.
36. Konarev AV, Beaudoin F, Marsh J, Vilkova NA, Nefedova LI, et al (2011)
Characterization of a glutenin-specific serine proteinase of Sunn bug Eurygaster
integricepts Put. J Agric Food Chem 59: 2462–70.
37. Hosseininaveh V, Bandani A, Hosseininaveh F (2009) Digestive proteolytic
activity in the Sunn pest, Eurygaster integriceps. J Insect Sci 9: 1–11.
38. Every D, Sutton KH, Shewry PR, Tatham AS, Coolbear T (2005) Specificity of
action of an insect proteinase purified from wheat grain infested by the New
Zealand wheat bug, Nysius huttoni. J Cereal Sci 42: 185–191.
Matrix Expansion in Coeliac Disease Mucosa
PLOS ONE | www.plosone.org 10 September 2014 | Volume 9 | Issue 9 | e106005
39. Greco L (1997) From the neolithic revolution to gluten intolerance: benefits and
problems associated with the cultivation of wheat. J Pediatr Gastroenterol Nutr
24: S14–16.
40. Qiao SW, Iversen R, Ra´ki M, Sollid LM (2012) The adaptive immune response
in celiac disease. Semin Immunopathol 34: 523–540.
41. Wang Z, Collighan RJ, Pytel K, Rathbone DL, Li X, et al (2012)
Characterization of heparin-binding site of tissue transglutaminase: its
importance in cell surface targeting, matrix deposition, and cell signaling. J Biol
Chem 287: 13063–13083.
42. Hayashida K, Stahl PD, Park PW (2008) Syndecan-1 ectodomain shedding is
regulated by the small GTPase Rab5. J Biol Chem 283: 35435–35444.
43. Schumann M, Richter JF, Wedell I, Moos V, Zimmermann-Kordmann M, et al
(2008) Mechanisms of epithelial translocation of the a(2)-gliadin-33mer in
coeliac sprue. Gut 57: 747–754.
44. Kimura A, Kishimoto T (2010) IL-6: regulator of Treg/Th17 balance.
Eur J Immunol; 40: 1830–1835.
45. Sapone A, Lammers KM, Mazzarella G, Mikhailenko I, Cartenı` M, et al (2009)
Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten
sensitivity and the autoimmune enteropathy celiac disease. Int Arch Allergy
Immunol 152:75–80.
46. Ferna´ndez S, Molina IJ, Romero P, Gonza´lez R, Pen˜a J, et al (2011)
Characterization of gliadin-specific Th17 cells from the mucosa of celiac disease
patients. Am J Gastroenterol 106: 528–538.
47. Harris KM, Fasano A, Mann DL (2010) Monocytes differentiated with IL-15
support Th17 and Th1 responses to wheat gliadin: implications for celiac
disease. Clin Immunol 135: 430–439.
48. Bernardo D, Garrote JA, Ferna´ndez-Salazar L, Riestra S, Arranz E (2007) Is
gliadin really safe for non-coeliac individuals? Production of interleukin 15 in
biopsy culture from non-coeliac individuals challenged with gliadin peptides.
Gut 56: 889–890.
49. Nanayakkara M, Lania G, Maglio M, Discepolo V, Sarno M, et al (2013) An
undigested gliadin peptide activates innate immunity and proliferative signaling
in enterocytes: the role in celiac disease. Am J Clin Nutr 98: 1123–1135.
50. Tuckova´ L, Novotna´ J, Nova´k P, Flegelova´ Z, Kveton T, et al (2002) Activation
of macrophages by gliadin fragments: isolation and characterization of active
peptide. J Leukoc Biol; 71:625–631.
51. Jelı´nkova´ L, Tuckova´ L, Cinova´ J, Flegelova´ Z, Tlaskalova´-Hogenova´ H (2004)
Gliadin stimulates human monocytes to production of IL-8 and TNF-a through
a mechanism involving NF-kB. FEBS Lett; 571: 81–85.
52. Londei M, Ciacci C, Ricciardelli I, Vacca L, Quaratino S, et al (2005) Gliadin as
a stimulator of innate responses in celiac disease. Mol Immunol; 42: 913–918.
53. Rakhimova M, Esslinger B, Schulze-Krebs A, Hahn EG, Schuppan D, et al
(2009) In vitro differentiation of human monocytes into dendritic cells by peptic-
tryptic digest of gliadin is independent of genetic predisposition and the presence
of celiac disease. J Clin Immunol 2009; 29: 29–37.
54. Chladkova B, Kamanova J, Palova-Jelinkova L, Cinova J, Sebo P, et al (2011)
Gliadin fragments promote migration of dendritic cells. J Cell Mol Med 15:
938–948.
55. Palova´-Jelı´nkova´ L, Da´nˇova´ K, Drasˇarova´ H, Dvorˇa´k M, Funda DP, et al (2013)
Pepsin digest of wheat gliadin fraction increases production of IL-1b via TLR4/
MyD88/TRIF/MAPK/NF-kB signaling pathway and an NLRP3 inflamma-
some activation. PLoS One; 8: e62426.
56. Caruso R, Marafini I, Sedda S, Del Vecchio Blanco G, Giuffrida P, et al (2014)
Analysis of the cytokine profile in the duodenal mucosa of refractory coeliac
disease patients. Clin Sci (Lond); 126: 451–458.
57. Tack GJ, van Wanrooij RL, Von Blomberg BM, Amini H, Coupe VM, et al
(2012) Serum parameters in the spectrum of coeliac disease: beyond standard
antibody testing—a cohort study. BMC Gastroenterol; 12: 159.
Matrix Expansion in Coeliac Disease Mucosa
PLOS ONE | www.plosone.org 11 September 2014 | Volume 9 | Issue 9 | e106005
